Inflammation is an action of the body’s immunity system to recover the injured tissues. However, inflammatory diseases are the diseases wherein this action of the immunity system gets compromised. Thus, inflammatory diseases in turn could lead to life threatening diseases as cancer and rheumatoid arthritis. https://www.databridgemarketresearch.com/reports/global-inflammatory-disease-drug-delivery-market
Inflammation is an action of the body’s immunity system to recover the injured tissues. However, inflammatory diseases are the diseases wherein this action of the immunity system gets compromised. Thus, inflammatory diseases in turn could lead to life threatening diseases as cancer and rheumatoid arthritis.
Global inflammatory disease drug delivery market is set to witness a substantial CAGR of 7.8% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of inflammatory diseases among population is the major factor for the growth of this market.
Inflammation is an action of the body’s immunity system to recover the injured tissues. However, inflammatory diseases are the diseases wherein this action of the immunity system gets compromised. Thus, inflammatory diseases in turn could lead to life threatening diseases as cancer and rheumatoid arthritis.
Global Market Insights adds a new report Global Pharmaceutical Drug Delivery Market Research Report for the period of 2023-2032 that shows the growth of the market is rising at a Steady CAGR to 2032.
The global topical drug delivery market is expected to register high revenue growth and reach a market size of USD 145.68 Billion by 2027, according to a current analysis by Emergen Research. The importance of topical drug formulations for pharmaceutical delivery is rapidly increasing, and rising demand and use of these types of products is contributing to increasing market size currently, and the trend for more convenient treatments at home is contributing to increasing market size.
Rare Disease Treatment Market Segmented By Hematology, Genetic Diseases, Neurological Diseases, Oncology Infectious Diseases, Inflammatory Diseases, Metabolic Diseases Therapeutic Area with Originator Drugs, Generic Drugs Type with Biologics, Organic Compounds Drug Class
Innovative treatments are being developed by researchers, who are mainly focusing on reducing inflammation by using immunosuppressive therapies. Although these treatments promise remission in patients, risk of complications or relapse from long-lasting therapy prevail as key concerns. Significant improvements in the healthcare industry will stimulate in dealing with the rising instances regarding rare inflammatory diseases.
Fatty acid supplements, encompassing a wide range of essential nutrients such as omega-3, omega-6, and omega-9, are gaining traction for their numerous health benefits. According to Persistence Market Research's projections, the market for fatty acid supplements can be expected to expand at a value based CAGR of 7% and show an increase in revenue from US$ 5,406.0 Mn to around US$ 10,834.9 Mn by 2032. The market's growth is propelled by increasing awareness of the health benefits associated with fatty acids, rising demand for dietary supplements, and a growing focus on preventive healthcare.
The increasing prevalence of autoimmune diseases among individuals and the rising number of patients suffering from SLE represents one of the major factors driving the demand for SLE drugs around the world Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/systemic-lupus-erythematosus-drugs-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Ulcerative Colitis. ... agent for long-term management. Long-term ... further evaluation of UC and biopsies of a sigmoid colon mass with low grade dysplasia.
Clindamycin Vag Cream 2% QD x 7 d. Alternative. Tinidazole 1 g po QD x 5 d ... Clindamycin Ovules 100mg Vag hs x 3 d. Bacterial Vaginosis - Pregnancy ...
The disease is highly prevalent in developed countries, especially in individuals who smoke. According to a study conducted by Persistence Market Research (PMR), demand for anti-inflammatory drugs and biologics for treating Crohn’s disease will gain traction in the near future. PMR forecasts that the global market for Crohn’s disease is set to reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period.
The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 Million Americans were diagnosed with Crohn’s & ulcerative colitis disorders, with most of them aged above 30. Growing occurrence of Crohn’s disease has triggered a robust demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has revealed that the incidence rate of Crohn’s disease in the country is 3.1 to 14.6 new cases per 100,000 population annually.
Global Ophthalmology Drugs & Devices Market is expected to reach USD 36.95. billion by 2025, from USD 27.52 billion in 2017 growing at a CAGR of 4.3% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
According to a latest report published by Future Market Insights (FMI), the global APOL1 mediated kidney disease market was valued at US$ 3.0 Bn in 2020 and is anticipated to witness a steady CAGR of over 4% during the forecast period (2020-2030).
This study forecasts that the global branded generics market revenue is likely to grow more than double by 2030. The current scenario is such that “Generic” names are more popular than the branded ones. For instance – “Amoxicillin” is a well-known drug to treat bacterial infections. However, it’s not “branded” by any means. The “branded” name is “Trimox”.
Big Market Research, PharmaPoint: Global Asthma Drug Market Size, Share, Strategies, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities. Big Market Research added a new research report "PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023". Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade. The largest unmet needs mainly reflect the high level of heterogeneity of the disease, the lack of patient compliance with the standard therapies, and the high cost of medications for asthma treatment. In addition, there is a lack of diagnostic tools to provide a reliable diagnosis of asthma in young children. Annualized asthma therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. Check complete report @ http://www.marketintelreports.com/report/allied0083/world-intravenous-iv-ibuprofen-market--opportunities-and-forecasts-2015--2022
Intravenous (IV) Ibuprofen Market is expected to garner $14.2 million by 2022. Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. Get sample copy for industry insight: https://goo.gl/QUDQ8k
The Pain Relief Patches Market, valued at US$ 1.2 billion in 2024, is projected to grow to US$ 1.9 billion by 2032, with a compound annual growth rate (CAGR) of 4.9%, according to a recent study by Persistence Market Research. Non-steroidal anti-inflammatory drug patches dominate the market with a leading share of 39.5%. In 2021, pain relief patches held 15% of the global transdermal patches market. Nanotechnology integration in pharmaceuticals has boosted sales, with various nanomaterials approved for medical use. A study on Kailo pain patch showed a 71% reduction in pain severity, cited in Anesthesia & Pain Research. Market size was $1.1B in 2023, estimated $1.2B in 2024, and forecasted $1.9B in 2032, with top 5 countries holding 54.2% market share.
The pharmaceutical suppositories market size was valued at $1.6 billion in 2022, and is estimated to reach $2.8 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Pharmaceutical suppositories, though not a novel concept, have gained momentum in recent years due to their advantages over traditional drug delivery methods. These solid or semi-solid formulations, designed for insertion into the rectum, vagina, or urethra, offer localized and systemic therapeutic effects. The ease of administration, avoidance of first-pass metabolism, and improved bioavailability are some of the key factors contributing to their rising popularity. Know More- https://www.alliedmarketresearch.com/pharmaceutical-suppositories-market-A12350
Liposomes NANO52 Foothill College List of marketed products Marketed product Drug used Target diseases Company DoxilTM or CaelyxTM Doxorubicin Kaposi s sarcoma ...
New Antituberculous Drugs Hail M. Al-Abdely, MD Consultant, Infectious Diseases King Faisal Specialist Hospital and Research Center Driving forces behind Drug ...
Nicotine USP, or United States Pharmacopeia-grade nicotine, is a high-purity form of nicotine that is used in a variety of pharmaceutical and industrial applications. The global nicotine USP market is expected to grow from USD 392.9 million in 2021 to USD 1,022.17 million by 2030, at a CAGR of 7.5% during the forecast period.
The driving forces behind industry growth and innovation include technological advancements, consumer awareness, regulatory changes, and market competition. Companies invest in research and development to create differentiated products, streamline manufacturing processes, and comply with evolving regulatory standards. Innovation hubs, industry partnerships, and investment in talent foster a culture of creativity and entrepreneurship driving continuous improvement and market expansion.
Increasing demand of nanotechnology owing to the development programs funded by both government and private sectors organization for cardiovascular and neurology based diseases is also expected to drive the market for healthcare nanotechnology.
The global Dry Eye Syndrome treatment market size was USD 4.29 Billion in 2022 and is expected to reach USD 6.21 Billion by 2032, and register a rapid revenue CAGR of 4.2% during the forecast period. Increasing geriatric population, technical developments in the industry, and rising awareness and adoption of treatment choices are major factors driving market revenue growth. Dry eye syndrome is becoming more common as a result of aging population, increasing use of Digital gadgets, and harmful effects of environmental conditions on eyes, among other factors.
Discover why India is the best choice for importing pharmaceuticals to Ethiopia. Explore top Indian pharmaceutical companies like Aliyan Pharmaceuticals.
A Novel Topical Transdermal Delivery System Mark S. Nestor, M.D., Ph.D. Director Center for Clinical and Cosmetic Research Aventura Florida RLX 085-rev 6.6.08 bh jb ...
The Scope of Musculoskeletal Disease Treatment and Costs Prof Stephen Graves University of Melbourne Is the maintenance of musculoskeletal well being the most ...
According to a new market report published by Persistence Market Research “Latin America Capnography Equipment Market: Brazil to Witness Highest Growth by 2021”, the capnography equipment market for Latin America was valued at USD 9.7 million in 2014 and is expected to expand at a CAGR of 17.5 % from 2014 to 2021, to reach USD 30.2 million by 2021.
Demystifying Probiotics: Role in Health and Disease Michel Farhat, PhD ... DBPC study N=326 children (3 5 years of age) Probiotic: NCFM or NCFM+Bi-07, ...
There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. For More Details: http://bit.ly/1Am23RE
Worldwide sales of rheumatoid arthritis diagnosis test kits are likely to reach ~US$ 600 Mn by the end of 2019, unveils the new research study by Persistence Market Research (PMR). According to the report, the rheumatoid arthritis diagnosis test market is estimated to grow by ~ 4% Y-O-Y by the end of 2020, primarily influenced by recent advancements in the rheumatoid arthritis diagnosis test market.
The Nanomedicine Market accounted to USD 95.6 billion in 2016 growing at a CAGR of 14.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Single Dose Radiotherapy Services Market 2020 Analysis and Review: Single Dose Radiotherapy Services Market by Therapy type – External Beam Radiotherapy and Internal Beam Radiotherapy for 2020 – 2030
Today, the introduction of MTP Kit in the market had made the abortion safer and easier. MTP Kit is a most reliable and safest medical abortion method utilized in the conclusion of an early pregnancy of fewer than 9 weeks of gestation. The best thing is that it helps women to execute an abortion at the private milieu of their home without putting their lives in danger. MTP Kit holds two generic drugs called Mifepristone and Misoprostol. Bet MTP Kit online from USGenericshop our online drug portal at most convincing rates and ensure faster delivery.
According to a new report published by Persistence Market Research, the global ischemic optic neuropathy treatment market valued at US$ 187.7 Mn in 2020, and is predicted to expand at a CAGR of close to 4% over the forecast period (2021-2031).
Worldwide sales of rheumatoid arthritis diagnosis test kits are likely to reach ~US$ 600 Mn by the end of 2019, unveils the new research study by Persistence Market Research (PMR).